Topics

U.S. FDA panel votes against approval for Nektar's opioid painkiller

16:42 EST 14 Jan 2020 | Reuters

Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller for adults with chronic low back pain for whom currently available therapies have been inadequate.

Original Article: U.S. FDA panel votes against approval for Nektar's opioid painkiller

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA panel votes against approval for Nektar's opioid painkiller"

Quick Search

Relevant Topic

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...